Moreover, the additional anti-tumor mechanism of tramadol was confirmed in vivo by preserving NK cell activity to maintain immune function and decrease the production of pro-inflammatory cytokines such as TNF-α and IL-6. This evidence concerns the gene TNF and neoplasm.